[Abugov]

Камензинду в морду:

DES Lower Rates of Death, MI in Elderly Compared With BMS
By Jason Kahn
Saturday, March 28, 2009

ORLANDO, FL—The largest real-world study of its kind in over 260,000 Medicare patients showed that drug-eluting stents (DES) reduce mortality and myocardial infarction (MI) rates with no increased risk of stroke or major bleeding compared with bare-metal stents (BMS) in elderly patients, according to a late breaking trial presentation Saturday, March 28, 2009, at the annual American College of Cardiology Scientific Session/i2 Summit.

The findings were simultaneously published in the Journal of the American College of Cardiology.